Carreno BM - Search Results

1

HLA-B37 and HLA-A2.1 molecules bind largely nonoverlapping sets of peptides.

Carreno BM, Anderson RW, Coligan JE, Biddison WE. Carreno BM, et al. Proc Natl Acad Sci U S A. 1990 May;87(9):3420-4. doi: 10.1073/pnas.87.9.3420. Proc Natl Acad Sci U S A. 1990. PMID: 2333291 Free PMC article.

2

Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.

Carreno BM, Turner RV, Biddison WE, Coligan JE. Carreno BM, et al. J Immunol. 1992 Feb 1;148(3):894-9. J Immunol. 1992. PMID: 1370522

3

The peptide binding specificity of HLA class I molecules is largely allele-specific and non-overlapping.

Carreno BM, Koenig S, Coligan JE, Biddison WE. Carreno BM, et al. Mol Immunol. 1992 Sep;29(9):1131-40. doi: 10.1016/0161-5890(92)90046-z. Mol Immunol. 1992. PMID: 1379681

4

Peptide binding to HLA-A2 and HLA-B27 isolated from Escherichia coli. Reconstitution of HLA-A2 and HLA-B27 heavy chain/beta 2-microglobulin complexes requires specific peptides.

Parker KC, Carreno BM, Sestak L, Utz U, Biddison WE, Coligan JE. Parker KC, et al. Among authors: carreno bm. J Biol Chem. 1992 Mar 15;267(8):5451-9. J Biol Chem. 1992. PMID: 1544922 Free article.

5

The 45 pocket of HLA-A2.1 plays a role in presentation of influenza virus matrix peptide and alloantigens.

Winter CC, Carreno BM, Turner RV, Koenig S, Biddison WE. Winter CC, et al. Among authors: carreno bm. J Immunol. 1991 May 15;146(10):3508-12. J Immunol. 1991. PMID: 2026879

6

Residues in pockets B and F of HLA-B27 are critical in the presentation of an influenza A virus nucleoprotein peptide and influence the stability of peptide - MHC complexes.

Carreno BM, Winter CC, Taurog JD, Hansen TH, Biddison WE. Carreno BM, et al. Int Immunol. 1993 Apr;5(4):353-60. doi: 10.1093/intimm/5.4.353. Int Immunol. 1993. PMID: 8494822

7

Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure disease-related antigenic peptides and exclude competitor peptides.

Truscott SM, Wang X, Lybarger L, Biddison WE, McBerry C, Martinko JM, Connolly JM, Linette GP, Fremont DH, Hansen TH, Carreno BM. Truscott SM, et al. Among authors: carreno bm. J Biol Chem. 2008 Mar 21;283(12):7480-90. doi: 10.1074/jbc.M709935200. Epub 2008 Jan 14. J Biol Chem. 2008. PMID: 18195006 Free PMC article.

8

Point mutations define positions in HLA-DR3 molecules that affect antigen presentation.

Mellins E, Arp B, Singh D, Carreno B, Smith L, Johnson AH, Pious D. Mellins E, et al. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4785-9. doi: 10.1073/pnas.87.12.4785. Proc Natl Acad Sci U S A. 1990. PMID: 2112748 Free PMC article.

9

Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.

Linette GP, Becker-Hapak M, Skidmore ZL, Baroja ML, Xu C, Hundal J, Spencer DH, Fu W, Cummins C, Robnett M, Kaabinejadian S, Hildebrand WH, Magrini V, Demeter R, Krupnick AS, Griffith OL, Griffith M, Mardis ER, Carreno BM. Linette GP, et al. Among authors: carreno bm. Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23662-23670. doi: 10.1073/pnas.1906026116. Epub 2019 Nov 4. Proc Natl Acad Sci U S A. 2019. PMID: 31685621 Free PMC article.

10

CTLA-4 ligation delivers a unique signal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X(L) induction.

Blair PJ, Riley JL, Levine BL, Lee KP, Craighead N, Francomano T, Perfetto SJ, Gray GS, Carreno BM, June CH. Blair PJ, et al. Among authors: carreno bm. J Immunol. 1998 Jan 1;160(1):12-5. J Immunol. 1998. PMID: 9551948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters